Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

The clindamycin phosphate 1.2%/BPO 2.5% combination therapy with
Power to please

Acanya Get – the once-daily combination optimized for both power and tolerability

Power to treat
Formulated to be one they’ll love to use

To see all of this brand’s ads on AdPharm, click here

Now available: dapsone in topical form.

First new FDA-approved chemical entity for topical acne treatment in a decade.

Works fast. 24% reduction in inflammatory lesions at 2 weeks.
Works well. 48% reduction in inflammatory lesions at 12 weeks.
Well tolerated. Most adverse events were mild to moderate.

Brand name: Aczone
Generic name/category: dapsone
Company: Allergan
Country/Market: USA, North America
Indication(s)/use: Topical treatment of acne vulgaris
Target: Healthcare Professionals (HCP)
Tagline: Calms inflammatory acne
Publication: Dermatology Times May 2009

Put a little muscle into it.
Primary analysis demonstrates significantly more patients rated clear or almost clear on IGA at 12 weeks.

Differin and skin care on AdPharm